Deutsche Gesellschaft für Pharmazeutische Medizin e.V. (DGPharMed)

What Deutsche Gesellschaft für Pharmazeutische Medizin e.V. (DGPharMed) does

Deutsche Gesellschaft für Pharmazeutische Medizin e.V. (DGPharMed) is a registered non-profit scientific-medical professional society (e.V.) headquartered in Düsseldorf, Germany. Founded in 1973 as Fachgesellschaft der Ärzte in der pharmazeutischen Industrie e.V. (FÄPI) and renamed to its current form in 1996, DGPharMed is the only German scientific-medical society exclusively focused on pharmaceutical medicine. It serves physicians, scientists, university graduates, and professionals working in pharmaceutical industry, medical device companies, contract research organizations, academic institutions, and clinical practice, covering the full drug development lifecycle from discovery through regulatory approval, benefit assessment, and practical medical application.

The society delivers its value proposition through a portfolio of professional development and networking services rather than commercial technology products. Core offerings include the PM/QM scientific journal (jointly with GQMA e.V., now being transitioned to a newsletter format), an Annual Congress (the 42nd edition held in Berlin in April 2025 with 200+ participants), online seminars and webinars, short training sessions (Kurzschulungen), a Young Professionals Mentoring Program, and a certification course on Health Technology Assessment (DGPharMed-Zertifikatskurs Basiswissen HTA). The underlying infrastructure comprises a website (dgpharmed.de), a private member portal (dgpharmed-intern.de), a newsletter system, LinkedIn presence, and a private member area. Specialized knowledge is organized into six Fachbereiche (eSolutions, Klinische Prüfung, HTA, Medical Affairs, Pharmakovigilanz, Regulatory Affairs & Medical Devices, and Digital Health), four Arbeitsgruppen (EU-HTA, Phytopharmaka, Real World Evidence, Register), and six regional Meet-Ups across Germany (Bayern, Berlin-Brandenburg, Mitteldeutschland, Norddeutschland, Nordrhein, Südwest).

DGPharMed generates revenue primarily through annual membership dues for physicians, scientists, graduates, and professionals, supplemented by registration and sponsorship fees from congresses, regional Meet-Ups, seminars, webinars, and certification courses. The organization is member-governed, with a board elected every two years, and operates with approximately 10 employees. Strategic partnerships with AWMF, Charlotte Fresenius Hochschule, GQMA, TMF, ISD, KKS-Netzwerk, and DACH-region sister societies provide institutional reach and policy influence, particularly in regulatory consultations on benefit assessment, medical registries, HTA, and the German Medical Research Act.

Name

Deutsche Gesellschaft für Pharmazeutische Medizin e.V. (DGPharMed)

Legal name

Deutsche Gesellschaft für Pharmazeutische Medizin e.V.

Website

https://dgpharmed.de

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

1–10 employees

Short description

DGPharMed is a non-profit German scientific-medical professional society serving physicians, scientists, and industry professionals across pharmaceutical medicine, delivering annual congresses, webinars, certification courses, and Fachbereiche-organized expertise spanning the full drug development lifecycle.

Ownership category

akta.pro rank

Product category

Professional Medical Society (Pharmaceutical Medicine)

NAICS

Professional, Scientific, and Technical Services (541)

SIC

Services-Health Services (8000)

akta.pro industry

PRIMARYEDAGANAJ

Healthcare & Clinical Professional Development (CME/CE)

Education/Educational Publishing & Learning Content/Professional Development & Training Materials

SECONDARYEDAAALAC

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy)

Education/Adult & Continuing Education/Professional Licensure & Continuing Professional Education (CE/CPE)

Keywords

• Pharmaceutical medicine society
• Professional medical association
• Clinical research education
• Health technology assessment training
• Pharmacovigilance certification

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: Annual membership dues for physicians, scientists, graduates, and professionals in pharmaceutical medicine
2. Event and Conference Revenue: Revenue from annual congresses, regional Meet-Ups, seminars, and online training events including certification courses

Pricing tiers

Distribution channels4 records

Marketing channels6 records

Core offering

DGPharMed is a scientific-medical professional society (Fachgesellschaft) that provides continuing education, networking, and professional development services to physicians, scientists, graduates, and industry professionals working in pharmaceutical medicine. Its offering centers on annual membership, the annual congress in Berlin, regional Meet-Ups in six German regions, the PM/QM scientific journal published jointly with GQMA e.V., online seminars and webinars, certification courses (notably the HTA certificate course), a mentoring program for young professionals, and formal position statements on regulatory and health-policy matters. The society is the only German Fachgesellschaft exclusively devoted to pharmaceutical medicine.

Product overview

DGPharMed is a scientific-medical professional society (Fachgesellschaft) for physicians, scientists, university graduates, and other professionals in pharmaceutical medicine. The organization offers a portfolio of professional development services including the PM/QM scientific journal, an annual congress, online seminars and webinars, short training sessions, a mentoring program, and certificate courses. The society also facilitates networking through regional Meet Ups and maintains specialized working groups (AG) and specialist sections (Fachbereiche) covering areas such as eSolutions, clinical trials, HTA, Medical Affairs, pharmacovigilance, and regulatory affairs. DGPharMed does not offer a commercial software product but provides educational, networking, and professional development services to its members.

Differentiator

Problem solved

Functional benefit

Products and services

• PM/QM Journal (Pharmaceutical Medicine / Quality Management)

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered major, core and minor.

• IFAPP (International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine)majorStrategic or Co-development Partner · 1 January 2022DGPharMed was a founding member of IFAPP since 1975, with membership ending in 2022. Cooperation between DGPharMed and IFAPP remains possible, with individual memberships still supported. Germany hosted ICPM conferences in 1984, 2000, and 2014 jointly organized with DGPharMed.
• AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.)coreStrategic or Co-development PartnerDGPharMed is an active member of AWMF, the network of scientific medical societies in Germany representing 162 member societies. DGPharMed participates in Delegiertenkonferenzen twice yearly and has members in AWMF commissions including 'Nutzenbewertung von Arzneimitteln' and 'in-vitro Diagnostik'. AWMF represents Germany in CIOMS.
• Charlotte Fresenius Hochschule (CFU)coreStrategic or Co-development PartnerDGPharMed cooperates with Charlotte Fresenius Universität in pharmaceutical medicine. The partnership aims to bundle competencies in teaching, research, and continuing education, and jointly offers the M.Sc. Pharmaceutical Medicine program to create a network of experts, researchers, and students.
• GQMA e.V.coreStrategic or Co-development PartnerTogether with GQMA e.V., DGPharMed publishes the PMQM journal (Pharmaceutical Medicine Quality Management), providing a platform for scientific publication in pharmaceutical medicine.
• TMF e.V. (Technologie- und Methodenplattform für die vernetzte medizinische Forschung)majorStrategic or Co-development PartnerDGPharMed participates in the TMF AG Register (working group on medical registries) as a permanent guest. The society co-organized TMF Registertage 2026 in Berlin and contributes to discussions on medical registers for research, quality assurance, and patient care improvement.
• ISD (Initiative Studienstandort Deutschland)majorStrategic or Co-development PartnerDGPharMed cooperates within the ISD initiative focused on strengthening Germany's position as a clinical research location. The society contributed to the ISD position paper on the Medizinforschungsgesetz (Medical Research Act).
• Universität für Weiterbildung Krems (Austria)minorStrategic or Co-development PartnerDGPharMed board member Christoph Gleiter serves as academic director for the MSc Clinical Research program at Danube University Krems, an online-focused clinical research master's degree.
• KKS-Netzwerk (Klinische Studienzentren-Netzwerk)majorStrategic or Co-development PartnerDGPharMed cooperates with the KKS-Netzwerk as part of broader efforts to strengthen clinical research in Germany, including joint statements on medical registry legislation.
• Partner societies in Austria and SwitzerlandminorStrategic or Co-development PartnerDGPharMed maintains cooperation with partner pharmaceutical medicine societies in Austria and Switzerland as part of regional DACH collaboration in pharmaceutical medicine.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• AWMF (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften): Umbrella association of 162 German scientific medical societies. DGPharMed is a member society and represents pharma medicine within this larger federation, which sets cross-specialty standards and policy positions.
• vfa (Verband Forschender Arzneimittelhersteller): German association of research-based pharmaceutical companies. While vfa represents the industry side and DGPharMed the physician/professional side, both influence German pharma policy and share stakeholders across drug development, regulatory affairs, and HTA.

Direct peers

• Faculty of Pharmaceutical Medicine (UK): UK professional body for pharmaceutical physicians offering training, certification, and standards. Comparable in mission (professional standards + education in pharma medicine) and structure (membership society with specialist recognition) to DGPharMed.
• American College of Clinical Pharmacology: US professional society advancing clinical pharmacology and pharmaceutical medicine through education, publications, and conferences. Directly mirrors DGPharMed's role as a learned society for physicians working across drug development.
• GQMA e.V. (Gesellschaft für Qualitätsmanagement in der pharmazeutischen Medizin): German quality management society in pharmaceutical medicine that co-publishes the PM/QM journal with DGPharMed. Operates in an immediately adjacent professional society niche with overlapping membership and joint content.
• KKS-Netzwerk (Klinische Studienzentren-Netzwerk): German network of academic clinical trial centers. DGPharMed cooperates with KKS-Netzwerk on joint statements and clinical research policy, and both organizations target the same population of clinical research physicians and trial personnel in Germany.
• International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP): Global federation of national pharmaceutical medicine associations. DGPharMed was a founding IFAPP member since 1975 and jointly hosted ICPM conferences, making IFAPP the closest organizational counterpart at the international level.

Others

• TMF e.V. (Technologie- und Methodenplattform für die vernetzte medizinische Forschung): German platform for networked medical research in which DGPharMed participates as a permanent guest in the AG Register working group and co-organizes TMF Registertage. TMF is an enabling/ecosystem partner rather than a direct competitor.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/dgpharmed

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Deutsche Gesellschaft für Pharmazeutische Medizin e.V. (DGPharMed)